Medical Seminar

Immuno-Oncology : The New Frontier

Chair

Akihiko Genma (Department of Pulmonary Medicine and Oncology)

Speaker

Naiyer A. Rizvi (Division of Hematology, Oncology of the Department of Medicine,Columbia University Medical Center, USA)

Co-host

Bristol-Myers K.K.
Ono Pharmaceutical Co., Ltd.

The Latest Treatment Strategy for EGFR Mutation Positive NSCLC

Chair

Tetsuya Mitsudomi (Division of Thoracic Surgery Department of Surgery Kinki University Faculty of Medicine)

Speaker

James Chih-Hsin Yang (Department of Medical Research, National Taiwan University Hospital, Taiwan)

Co-host

Nippon Boehringer Ingelheim Co., Ltd.

A Personalized Approach to MBC: Current Status and Future Perspectives

Chair

Yoshinori Ito (Breast Medical Oncology, Breast Cancer Center, Cancer Institute Hospital)

Speaker

Sung-Bae Kim (Department of Oncology Asan Medical Center University of Ulsan College of Medicine, Korea)

Co-host

Eisai Co., Ltd.

A Paradigm Shift of Pancreatic Cancer Treatment - Abraxane-based Chemotherapy

Chair

Yasutsuna Sasaki (Division of Medical Oncology, Department of Internal Medicine, Showa University School of Medicine)

Speaker

Manuel Hidalgo (Spanish National Cancer Research Centre (CNIO), Translational Research, Clinical Research Program, and Gastrointestinal Cancer Clinical Research Unit, Spain)

Co-host

Taiho Pharmaceutical Co., Ltd.

Treatment Strategy of HER2 Positive MBC Based on the Point of View of Medical Oncologists 〜 Role of New Generation HER2-Targeted Drugs 〜

Chair

Hiroko Yamashita (Hokkaido University Hospital Breast Surgery)

Speakers

Yoichi Naito (Division of Experimental Therapeutics Exploratory Oncology Research & Clinical Trial Center, and Division of Breast and Medical Oncology National Cancer Center Hospital East)
Koji Matsumoto (Department of medical oncology, Hyogo Cancer Center)

Co-host

Chugai Pharmaceutical Co., Ltd.

Current Trend of Cancer Stem Cell Research and The Therapeutic Approaches

Chair

Takahiro Ochiya (Division of Molecular and Cellular Medicine, Group for Research of Molecular Functions and Targets, National Cancer Center Research Institute)

Speaker

Hideyuki Saya (Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University)

Co-host

Sumitomo Dainippon Pharma Co., Ltd.

Clinical Sequencing for Cancer Precision Medicine

Chair

Hiroyuki Mano (Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo)

Speaker

Takashi Kohno (Division of Genome Biology, National Cancer Center Research Insititute)

Co-host

Illumina K.K.

Current and Future Treatments of Bone Metastases

Chair

Yoichi Nakanishi (Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University)

Speaker

Nobuhiko Seki (Division of Medical Oncology, Teikyo University School of Medicine)

Co-host

Daiichi Sankyo Co., Ltd.

Chemotherapy in Gastric Cancer Focusing on QOL

Chair

Kensei Yamaguchi (Saitama Cancer Center, Department of Gastronerology)

Speaker

Taro Sato (Osaka University, Graduate School of Medicine, Department of Frontier Science for Cancer and Chemotherapy)

Co-host

Eli Lilly Japan K.K.

PET/CT of Malignant Lymphoma and the Lugano Classification

Chair

Nagara Tamaki (Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine)

Speaker

Ukihide Tateishi (Department of Diagnostic Radiology and Nuclear Medicine, Tokyo Medical and Dental University Graduate School of Medicine)

Co-host

Nihon Medi-Physics Co., Ltd.

Salvage Therapy Options for Metastatic Colorectal Cancer in the Continuum of Care

Chair

Narikazu Boku (Gastrointestinal Medical Oncology Division, National Cancer Center Hospital)

Speaker

Axel Grothey (Medical Oncology, Mayo Clinic Rochester, USA)

Co-host

Bayer Yakuhin, Ltd.

New Potential Role of Anti-Angionegesis Agents for the Treatment of Advanced NSCLC

Chair

Kouji Takeda (Department of Medical Oncology, Osaka City General Hospital)

Speaker

Isamu Okamoto (Center for Clinical and Translational Research, Kyushu University Hospital)

Co-host

Chugai Pharmaceutical Co., Ltd.

Patient Self-Reporting of Symptoms and the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events

Chair

Yasuo Ohashi (Department of Integrated Science and Engineering for Sustainable Society, Chuo University)

Speaker

Amylou C. Dueck (Section of Biostatistics, Division of Health Sciences Research, Mayo Clinic)

Co-host

Eli Lilly Japan K.K.

Immuno Checkpoint Inhibitors - Current Status and Future Prospects

Chair

Noboru Yamamoto (Department of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center)

Speaker

Roy S. Herbst (Yale Comprehensive Cancer Center, Yale School of Medicine, USA)

Co-host

AstraZeneca K.K.

Management of Febrile Neutropenia in Patients Undergoing Chemotherapy

Chair

Kazuo Tamura (General Medical Research Center, School of Medicine, Fukuoka University)

Speaker

Yoshinobu Kanda (Division of Hematology, Department of Medicine, Jichi Medical University Division of Hematology, Saitama Medical Center, Jichi Medical University)

Co-host

Taisho Toyama Pharmaceutical Co.,
Toyama Chemical Co., Ltd.

How to Determine the Optimal Traetment Strategy for Colorectal Cancer

Chair

Atsushi Ohtsu (Exploratory Oncology Research & Clinical Trial Center, National Cancer Center)

Speaker

Eric Van Cutsem (Medicine Gastrointestinal Oncology Unit University Hospitals Leuven, Belgium)

Co-host

Taiho Pharmaceutical Co., Ltd.

Progress and Challenge on Lymphoma Treatment

Chair

Shinsuke Iida (Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences)

Speaker

Junji Suzumiya (Shimane University Hospital Cancer Center ・Oncology/Hematology)

Co-host

Chugai Pharmaceutical Co., Ltd.

Treatment for HER2 Positive Gastric Cancer ～Lesson from Therapeutic Strategy of HER2 Positive Breast Cancer

Chair

Kei Muro (Department of Clinical Oncology and Outpatient Treatment Center, Aichi Cancer Center Hospital)

Speakers

Hiroji Iwata (Department of Breast Oncology, Aichi Cancer Center Hospital)
Kei Muro (Department of Clinical Oncology and Outpatient Treatment Center, Aichi Cancer Center Hospital)

Co-host

Chugai Pharmaceutical Co., Ltd.

Key Insights into HPV for Head and Neck Cancer Tumor Biology and Treatment

Chair

Makoto Tahara (Division of Head and Neck Medical Oncology, National Cancer Center Hospital East)

Speaker

Jan B. Vermorken (Department of Medical Oncology, Antwerp University Hospital, Belgium)

Co-host

Merck Serono Co., Ltd.

Chemotherapy for mCRC ～Beyond KRAS and Further Therapeutic Strategy～

Chair

Yuh Sakata (Misawa City Hospital)

Speaker

Kensei Yamaguchi (Department of Gastroenterology, Saitama Cancer Center)

Co-host

Merck Serono Co., Ltd.

Actual Team Medical Care of Myelodysplastic Syndromes(MDS)：from the Standpoint of Doctors and Nurses

Chair

Arinobu Tojo (Division of Molecular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo)

Speakers

Nobuhiro Ohno (Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo)
Yukari Tsuru (Department of Nursing, Research Hospital, The Institute of Medical Science, The University of Tokyo)

Co-host

Nippon Shinyaku Co., Ltd.

Lymphocytosis during Dasatinib Therapy ; Its Clinical Features and Application

Chair

Kohmei Kubo (Aomori Prefectural Central Hospital, Department of Hematology)

Speaker

Takashi Kumagai (Ohme Municipal General Hospital, Department of Hematology)

Co-host

Bristol-Myers K.K.

To Achieve 50% In Five Years Overall Survival Rate In Stage Ⅳ NSCLC

Chair

Noriyuki Masuda (Kitasato University School of Medicine, Department of Respiratory Medicine)

Speaker

Katsuyuki Kiura (Department of Allergy & Respiratory Medicine (Thoracic Oncology), Okayama University Hospital)

Co-host

Chugai Pharmaceutical Co., Ltd.

How Do We Apply the Clinical Practice Guideline of Breast Cancer 2015 to Daily Practice?
～The Positioning of Everolimus in the Treatment of Hormone-Receptor Positive Metastatic or Recurrent Breast Cancer Patients～

Chair

Hirofumi Mukai (Division of Breast and Medical Oncology, National Cancer Center Hospital East)

Speakers

Junji Tsurutani (Department of Medical Oncology, Kinki University Faculty of Medicine)
Tomomi Fujisawa (Department of Breast Oncology, Gunma Prefectural Cancer Center)

Co-host

Novartis Pharma K.K.

Optimal Strategy in Management of ALK Positive Lung Cancer

Chair

Yuichiro Ohe (National Cancer Center Hospital)

Speaker

Tony S. K. Mok (Department of Clinical Oncology, Chinese University of Hong Kong, China)

Co-host

Pfizer Japan Inc.
Merck Serono Co., Ltd.

Evolving Paradigms in the Diagnosis and Management of Advanced
Neuroendocrine Tumors

Chair

Junji Furuse (Department of Medical Oncology, Kyorin University School of Medicine)

Recent Topics and Pitfalls in Pathology Diagnosis of Gastrointestinal Neuroendocrine Tumor : GEP-NET

Speaker

Atsuko Kasajima (Department of Pathology, Tohoku University Hospital / Tohoku University Comprehensive Education Center for Community Medicine)

Long-term Clinical Outcome of Everolimus and Drug Selection Criteria for Advanced pNET～Kyushu University Experience～

Speaker

Tetsuhide Ito (Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University)

Co-host

Novartis Pharma K.K.

Tumor Lysis Syndrome

Chair

Kenichi Ishizawa (Department of Hematology and Cell Therapy, Yamagata University Faculty of Medicine)

Guidance of Tumor Lysis Syndrome(TLS)：Risk Evaluation, Prophylaxis, and Treatment

Speaker

Michihide Tokuhira (Department of Hematology, Saitama Medical Center, Saitama Medical University)

Management of Tumor Lysis Syndrome(TLS) by the Pharmacist

Speaker

Maki Nemoto (Department of Pharmacy and Pharmaceutical Sciences, Cancer Institute Hospital)

Co-host

Sanofi K. K.

Treatment Strategy for ALK-Positive NSCLC in Japan and US

Chair

Kazuhiko Nakagawa (Department of Medical Oncology, Kinki University, Faculty of Medeicine)

Speakers

David Ross Camidge (Division of Medical Oncology, University of Colorado Denver School of Medicine, USA)
Akira Inoue (Department of Palliative Medicine, Tohoku University School of Medicine)

Co-host

Chugai Pharmaceutical Co., Ltd.

Treatment Strategy for mCRC in All RASwt

Chair

Chikashi Ishioka (Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University)

Speaker

Josep Tabernero (Medical Oncology Department, Vall d' Hebron University Hospital, Vall d'Hebron Institute of Oncology (V.H.I.O.), Spain)

Co-host

Chugai Pharmaceutical Co., Ltd.

Biological Perspectives for New Therapeutic Strategies in B-cell Lymphomas

Chair

Kensei Tobinai (Department of Hematology, National Cancer Center Hospital)

Speaker

Elias Campo (Hematopathology Unit, Hospital Clinic, University of Barcelona, Spain)

Co-host

Zenyaku Kogyo Co., Ltd.

Treatment Strategy for Newly Diagnosed Multiple Myeloma

Chair

Shinichiro Okamoto (Division of Hematology Department of Internal Medicine Keio University School of Medicine)

Speaker

Mohamad Mohty (Hematology and cellular therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie, Paris, France)

Co-host

Janssen Pharmaceutical K.K.
Takeda Pharmaceutical Company Limited

Chair

Hironobu Minami (Department Oncology and Hematology Kobe University)

Recent Progress in Molecular Targeting Therapy for Thyroid Cancer

Speaker

Naomi Kiyota (Department Oncology and Hematology, Kobe University)

Future Prospects of Sorafenib on Thyroid Cancer from the 1st Interim Analysis of Post Marketing Surveillance

Speaker

Hironobu Minami (Department Oncology and Hematology, Kobe University)

Co-host

Bayer Yakuhin, Ltd.

Challenges for Cancer Precision Medicine
Based on the Nationwide Cancer Genome Screening Projects in Japan

Chair

Kazuto Nishio (Department of Genome Biology, Kinki University Faculty of Medicine)

Speaker

Takayuki Yoshino (Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East)

Co-host

Thermo Fisher Scientific Life Technologies Japan Ltd.

Personalizing Therapy for Advanced Prostate Cancer : How to Treat the Individual

Chair

Hirotsugu Uemura (Kinki University Faculty of Medicine, Department of Urology)

Speaker

Tomasz M. Beer (Oregon Health & Science University, Knight Center Institute, USA)

Co-host

Janssen Pharmaceutical Companies
AstraZeneka K.K.

Treatment Strategy for Future Non-small Cell Lung Cancer

Chair

Kouichi Goto (Division of Thoracic Oncology, National Cancer Center Hospital East)

Speaker

Nobuyuki Yamamoto (Third Department of Internal Medicine, Wakayama Medical University)

Co-host

Eli Lilly Japan K.K.

Actual Management of Febrile Neutropenia by Pegfilgrastim in the United States

Chair

Kaoru Kubota (Medical Oncology Division, Nippon Medical School Hospital)

Speaker

Naoto T. Ueno (Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, USA)

Co-host

Kyowa Hakko Kirin Co., Ltd.

The New Era of the Chemotherapy for Advanced Gastric Cancer：the Transition from the Hospitalized Care to the Outpatient Care
- How Should the Oncology Team Take Care of Patients ? -

Chair

Atsushi Miyamoto (Division of Pharmaceutical Health Care and Sciences, Sapporo Medical University)

Speakers

Toshihiro Hama (Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research)
Mitsugi Yamada (Outpatient Oncology Unit, Chiba Cancer Center Hospital)

Co-host

Yakult Honsha Co., Ltd.

Morning Seminar

The View of Cancer Pain and Its Management

Chair

Akihiko Watanabe (Department of Anesthesiology, Palliative Care, Sapporo Kiyota Hospital)

Speaker

Tatsuo Yamamoto (Department of Anesthesiology, Kumamoto University Hospital)

Co-host

Showa Yakuhin Kako Co., Ltd.

Evidence and Practice of Colorectal Cancer Chemotherapy

Chair

Atushi Sato (Department of Medical Oncology, Hirosaki University Graduate School of Medicine)

Speaker

Kei Muro (Department of Clinical Oncology and Outpatient Treatment Center, Aichi Cancer Center Hospital)

Co-host

Nichi-Iko Pharmaceutical Co., Ltd.

Problems for Every Oncologist and the Roles for Medical Oncologists in Building the Systems that Provide Medical and Health Care Services for Subjects with Genetic Predisposition to Cancer

Chair

Akihiro Sakurai (Sapporo Medical University School of Medicine)

Increasing Roles of Medical Oncologists in Genetic Medicine

Speaker

Hiromi Nakata (Shinjuku Minerva Clinic, and Japanese Society of Ethical, Legal and Social Issues)

Ethical, Legal and Social Issues in Genetic Medicine

Speaker

Hiromu Mochizuki (Tokyo Flex Law Office, and Japanese Society of Ethical, Legal and Social Issues)

For Appropriate Use of Genetic Information

Speaker

Masayoshi Tsutsumi (SRL,Inc. and Council for Protection of Individual Genetic Information)

Co-host

BGI Health JAPAN K.K.

Lenvatinib: New Molecular-targeted Drug for Thyroid Cancer

Chair

Hiroshi Takami (Ito Hospital / Department of Surgery, Teikyo University)

Speaker

Makoto Tahara (Department of Head and Neck Medical Oncology, National Cancer Center Hospital East)

Co-host

Eisai Co., Ltd.

Comprehensive Treatments with Novel Agents for Multiple Myeloma

Chair

Takanori Teshima (Graduate School of Medicine, Hokkaido University)

Speaker

Toshihiro Miyamoto (Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences)

Co-host

Celgene K.K.

Evening Seminar

Current Status and Future Perspective of Adjuvant Chemotherapy for Colon Cancer

Chair

Ichinosuke Hyodo (Division of Gastroenterology, University of Tsukuba)

Speaker

Kentaro Yamazaki (Division of Gastrointerestinal Oncology, Shizuoka Cancer Center)

Co-host

Chugai Pharmaceutical Co., Ltd.

Addressing Current Questions and Controversies in the Management of Early Breast Cancer

Chair

Hiroji Iwata (Aichi Cancer Center Hospital)

Speaker

Martine J. Piccart (Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Belgium)

Co-host

Chugai Pharmaceutical Co., Ltd.

Cancer Immunotherapy Comes of Age

Chair

Koji Tamada (Department of Immunology, Yamaguchi University Graduate School of Medicine)

Speaker

Yutaka Kawakami (Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University Graduate School of Medicine)

Co-host

MSD K.K.

To Build a Consensus by the Voluntary Oncologists and Dermatologists, for the Management of Skin Toxicity Associated with Molecularly-Targeted Drugs

Chairs

Nobuyuki Yamamoto (Third Department of Internal Medicine, Wakayama Medical University)
Makoto Kawashima (Department of Dermatology, Tokyo Women's Medical University)

A Feedback from the Consensus Meeting with Volunteer Medical Oncologists and Dermatologists

Speakers

Naoya Yamazaki (Department of Dermatologic Oncology, National Cancer Center Hospital)
Yoshio Kiyohara (Division of Dermatology, Shizuoka Cancer Center)
Tomohiro Nishina (Department of Gastroenterology, National Hospital Organization Shikoku Cancer Center)

Co-host

Non-proft Organization JASMIN

"Aiming for a Cure" Adjuvant Chemotherapy for Breast Cancer

Chair

Noriyuki Katsumata (Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital)

Speaker

Fumikata Hara (Department of Breast and Medical Oncology, Shikoku Cancer Center)

Co-host

Sanofi K. K.

Current Treatment Strategy for Metastatic Colorectal Cancer

Chair

Eishi Baba (Kyushu University Faculty of Medical Sciences, Department of Comprehensive Clinical Oncology)

Speaker

Narikazu Boku (Gastrointestinal Medical Oncology Division, National Cancer Center Hospital)

Co-host

Daiichi Sankyo Co., Ltd.

Here Lies RCT(Born 1946- Died 2015)

Chair

Fumio Imamura (Department of Thoracic Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases)

Speaker

Hideo Kunitoh (Department of Medical Oncology, Japanese Red Cross Medical Center)

Co-host

AstraZeneca K.K.

Bone Scan Index(BSI)as a Management Tool for Bone Metastasis

Chair

Kazuo Kubota (Division of Nuclear Medicine, Department of Radiology, National Center for Global Health and Medicine)

Potential of BSI for Bone Metastasis Monitoring

Speaker

Motohide Uemura (Department of Urology, Osaka University Graduate School of Medicine)

The Evaluation of Bone Metastasis Treatment for Prostate Cancer

Speaker

Hiroji Uemura (Department of Urology and Renal Transplantation, Yokohama City University Medical Center)

Co-host

FUJIFILM RI Pharma Co., Ltd.

Publication Ethics Seminar

Chair

Anthony T.C. Chan (Sir YK Pao Center for Cancer and HK Cancer Institute, The Chinese University of Hong Kong, China)

Speaker

David Williamson (The Adis Journals Editorial Office, Springer, New Zealand)

Co-host

Springer Japan KK
Springer Healthcare Business Unit

Personalized Therapy for Colorectal Cancer

Chair

Nobuyuki Mizunuma (Cancer Institute Hospital)

Speaker

Hiroya Taniguchi (Aichi Cancer Center Hospital)

Co-host

Takeda Pharmaceutical Company Limited

Countermeasures against Reactivation of Hepatitis B Viral Infection following Chemotherapy: Is It Necessary in Patients with Solid Tumors?

Chair

Satoshi Mochida (Department of Hepatology & Gastroenterology Faculty of Medicine Saitama Medical University)

Speaker

Masafum Ikedai (Department of Hepatobioliary and Pancreatic Oncology, National Cancer Center Hospital East)

Co-host

Bristol-Myers K.K.

From Bench-to-Bedside　
Trends and Clinical Application of the Cancer Genetic Screening that Medical Oncologist Should Know

Chair

Kiyohiko Hatake (Japanese Foundation for Cancer Research Cancer Institute Hospital Hematology Oncology)

Speaker

Shunsuke Kato (Department of Medical Oncology Juntendo University)

Co-host

ARKRAY Marketing, Inc.

Palliative Care on Chemotherapy 〜Side Effect vs QOL vs Treatment Effect

Chair

Yuichi Ando (Department of Clinical Oncology and Chemotherapy, Nagoya University)

Speaker

Takako Nakajima (Department of Clinical Oncology, St.Marianna University School of Medicine)

Co-host

Hisamitsu Pharmaceutical Co., Inc.
Kyowa Hakko Kirin Co., Ltd.